Cargando…
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples
Coagulation cofactors profoundly regulate hemostasis and are appealing targets for anticoagulants. However, targeting such proteins has been challenging because they lack an active site. To address this, we isolate an RNA aptamer termed T18.3 that binds to both factor V (FV) and FVa with nanomolar a...
Autores principales: | Soule, Erin E., Yu, Haixiang, Olson, Lyra, Naqvi, Ibtehaj, Kumar, Shekhar, Krishnaswamy, Sriram, Sullenger, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808741/ https://www.ncbi.nlm.nih.gov/pubmed/35114109 http://dx.doi.org/10.1016/j.chembiol.2022.01.009 |
Ejemplares similares
-
Applications and future of aptamers that achieve rapid-onset anticoagulation
por: Yu, Haixiang, et al.
Publicado: (2023) -
ptFVa (Pseudonaja Textilis Venom-Derived Factor Va) Retains Structural Integrity Following Proteolysis by Activated Protein C
por: Schreuder, Mark, et al.
Publicado: (2021) -
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway
por: Song, Xirui, et al.
Publicado: (2023) -
Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction
por: Sun, Junjiang, et al.
Publicado: (2022) -
Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort Study
por: Mohan, Aditya A., et al.
Publicado: (2022)